船橋市立医療センターは、千葉県船橋市にある医療機関。船橋市立の病院である。 人口約60万人を擁する船橋市と東葛飾南部地域における中核病院である。病院の敷地は、金杉集落の住民によって寄付されたもので、丁度、垂直に削られた台地に隣接した位置にある。1994年より東葛南部医療圏初となる救命救急センターを設置。

During the past decade, Funabashi Municipal Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Funabashi Municipal Medical Center" #1 sponsor was "Bayer" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Juntendo University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Funabashi Municipal Medical Center" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Funabashi Municipal Medical Center" are "Uterine Fibroids" (2 trials), "Acute Heart Failure" (1 trials), "Acute Ischemic Stroke" (1 trials), "Chronic Pain" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Funabashi Municipal Medical Center" in a lesser frequency.

Most popular intervention types in "Funabashi Municipal Medical Center" are "Drug" (7 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Vilaprisan (BAY1002670)" (2 trials), "DS1040b" (1 trials), "Empagliflozin 10 MG" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Funabashi Municipal Medical Center" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Funabashi Municipal Medical Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Funabashi Municipal Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Funabashi Municipal Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".